Incidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test Results
Open Access
- 23 March 2005
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 293 (12), 1471-1476
- https://doi.org/10.1001/jama.293.12.1471
Abstract
Cervical cancer screening recommendations in the United States have been recently updated and now advise using an interval of 3 years between screenings in healthy women 30 years or older who have normal cytology results and who test negative for oncogenic (cancer-associated) human papillomavirus (HPV) DNA.1,2 The recommended interval is 6 to 12 months for women with normal cytology results and detectable oncogenic HPV. If no HPV test is conducted, 3 consecutive normal annual Papanicolaou (Pap) smear results are required before the Pap smear frequency is changed to once every 2 or 3 years. Support for these recommendations comes from several large observational studies.1-5Keywords
This publication has 11 references indexed in Scilit:
- Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesionsBritish Journal of Cancer, 2004
- Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for ScreeningObstetrics & Gynecology, 2004
- Human Papillomavirus Type 16 and Immune Status in Human Immunodeficiency Virus-Seropositive WomenJNCI Journal of the National Cancer Institute, 2003
- Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort AnalysisJNCI Journal of the National Cancer Institute, 2003
- Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virusThe American Journal of Medicine, 2001
- Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities: A Systematic ReviewJournal of Lower Genital Tract Disease, 2001
- PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changesJournal of Clinical Pathology, 2000
- Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalitiesPublished by Wolters Kluwer Health ,2000
- Cervicovaginal Human Papillomavirus Infection in Human Immunodeficiency Virus-1 (HIV)-Positive and High-Risk HIV-Negative WomenJNCI Journal of the National Cancer Institute, 1999
- Low-Grade Papanicolaou Smears and the Bethesda System: A Prospective Cytohistopathologic AnalysisPublished by Wolters Kluwer Health ,1995